MedTrace Logo

Food Insecurity in Oncology

NCT05176743 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2022-10-05

No results posted yet for this study

Summary

This trial will examine the feasibility and preliminary effectiveness of providing unconditional cash transfers to food insecure female breast and gynecologic cancer patients.

Approximately one-third of cancer survivors report food insecurity, characterized by limited access to adequate food for active, healthy living because of a lack of money and other resources. Unconditional cash transfers offer direct monetary assistance that can be used to meet immediate food or other financial needs and may positively impact health care resource utilization and health-related quality of life.

Conditions

Interventions

BEHAVIORAL

Unconditional Cash Transfer (UCT)

The UCT consists of three $100 VISA merchandise cards provided monthly via mail to participants randomized to the intervention arm. Merchandise cards can be used anywhere that VISA is accepted. Participants in the UCT arm will also receive Usual Care, including referral to the patient support services team and nutritional pamphlets.

Sponsors & Collaborators

  • University of New Mexico Cancer Center

    collaborator OTHER

  • Wake Forest University Health Sciences

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • New Mexico Cancer Research Alliance

    lead OTHER

Principal Investigators

  • Jean A McDougall, PhD, MPH · University of New Mexico, Internal Medicine/Epidemiology, Biostatistics & Preventive Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-30
Primary Completion
2022-03-02
Completion
2022-06-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05176743 on ClinicalTrials.gov